P-593. Does Dolutegravir increase hypercholesterolemia and/or hypertriglyceridemia?
Sign Up to like & getrecommendations! Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae631.791
Abstract: Abstract Background Antiretroviral therapy improved prognosis of people living with HIV (PLWA). WHO recommends Dolutegravir as the preferred treatment option for HIV in all populations considering its high genetic barrier and rare adverse effects compared… read more here.
Keywords: hypercholesterolemia; 593 dolutegravir; tld; hypercholesterolemia hypertriglyceridemia ... See more keywords